NYSE

Autoliv, Inc. (ALV)

550 Thanks from members

Autoliv, Inc. (ALV) displays mixed market sentiment as Q2 2026 earnings beat revenue and EPS estimates driven by strong Asia growth and cost savings, though weighed down by restructuring costs in Türkiye, margin pressures, and cautious analyst stances.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →